The Effect of Beta Blockers on the Clinical Course and Hemodynamics in Patients With Dilated Cardiomyopathies`

Q: What is the clinical evidence from this study?

Population: Dilated cardiomyopathy. Intervention: Beta blockers.

Q: What does this research mean for the field?

Dilated cardiomyopathy is characterized by chamber dilatation, impaired contractile function, and chronic heart failure, defined by a left ventricular ejection fraction below 45% and left ventricular diastolic cavity size exceeding 6 cm. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

Bakamov Dilshod

doi:10.17605/osf.io/672cu

December 28, 2020International Engineering Journal For Research & DevelopmentOpen Access

The Effect of Beta Blockers on the Clinical Course and Hemodynamics in Patients With Dilated Cardiomyopathies`

View Full Paper

Ask AI

Bookmark

Share

Why the study?

Dilated cardiomyopathy is a common myocardial disease characterized by LV dilation, impaired contractile function, and progressive chronic heart failure, necessitating evaluation of beta blockers' effects on clinical course and hemodynamics.

Key Points

To review the clinical characteristics, diagnostic thresholds, and therapeutic impact of beta blockers on hemodynamic function in patients with dilated cardiomyopathy.
Assessed global and regional epidemiological metrics of dilated cardiomyopathy prevalence.
Evaluated diagnostic criteria according to the 2013 ACCF/AHA Guideline for the Management of Heart Failure, defining cardiomyopathy by left ventricular ejection fraction <45% and diastolic cavity diameter >6 cm.
Dilated cardiomyopathy represents 60% of all cardiomyopathy presentations, affecting 5 to 8 per 100,000 individuals globally and 36 per 100,000 individuals in the United States.
The clinical course is defined by chamber enlargement, contractile dysfunction, and progressive chronic heart failure associated with severe left ventricular enlargement and systolic depression.

PICO

P

Population

Dilated cardiomyopathy

I

Intervention / Comparator

Beta blockers

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Supports beta-blocker use in dilated cardiomyopathy per 2013 criteria; reinforces ACCF/AHA guidance for hemodynamic management.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bakamov Dilshod (2020) studied Dilated cardiomyopathy. Beta blockers was evaluated.

synapsesocial.com/papers/6ac19d70aeea5716e8c6c6b2 https://doi.org/10.17605/osf.io/672cu

View Full Paper

Ask AI

Bookmark

Share

The Effect of Beta Blockers on the Clinical Course and Hemodynamics in Patients With Dilated Cardiomyopathies`

Key Points

PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

The Effect of Beta Blockers on the Clinical Course and Hemodynamics in Patients With Dilated Cardiomyopathies`

Key Points

PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading